THEOLAIR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Theolair, and what generic alternatives are available?
Theolair is a drug marketed by 3M and Medicis and is included in six NDAs.
The generic ingredient in THEOLAIR is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Theolair
A generic version of THEOLAIR was approved as theophylline by RHODES PHARMS on September 1st, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for THEOLAIR?
- What are the global sales for THEOLAIR?
- What is Average Wholesale Price for THEOLAIR?
Summary for THEOLAIR
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 171 |
| Patent Applications: | 3,898 |
| DailyMed Link: | THEOLAIR at DailyMed |
US Patents and Regulatory Information for THEOLAIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3m | THEOLAIR | theophylline | SOLUTION;ORAL | 086107-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| 3m | THEOLAIR-SR | theophylline | TABLET, EXTENDED RELEASE;ORAL | 089132-001 | Jul 16, 1987 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| 3m | THEOLAIR-SR | theophylline | TABLET, EXTENDED RELEASE;ORAL | 088369-001 | Jul 16, 1987 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Medicis | THEOLAIR | theophylline | TABLET;ORAL | 086399-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
